Michael Macdonnell has been named as chief operating officer of biotechnology company Sensyne Health.
Macdonnell was previously director of global deployment at Google Health and is a former director of strategy at NHS England.
He will take up the newly created role later this month.
Sensyne Health uses artificial intelligence algorithms to analyse anonymised patient data to help pharmaceutical companies accelerate the development of new medicines.
Related Posts
-
June 28, 2022
Dobson recently stepped down as chair of Schroders, and will take over the chair role at Berkeley Group from Glyn Barker in September.
-
August 30, 2022
The airline’s boardroom makeover brings in three new non-executive directors: Harald Eisenächer, Detlef Trefzger and Ryanne van der Eijk.
-
January 23, 2023
Sir John Kingman will join as a NED and take over from Crawford Gillies as chair of the group’s ring-fenced banking arm, Barclays UK.
-
August 16, 2022
Blanc will be a non-executive director and joins from Aviva, where she has been group chief executive officer since 2020.